Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can eye exercises tame migraines? new trial investigates

NCT ID NCT07254598

Symptom relief Sponsor: Facultad de Enfermería, Fisioterapia y Podología (FEFP) Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding gentle eye muscle techniques to standard neck and jaw manual therapy can reduce pain and disability in people with migraine without aura. Eighty-four adults aged 18–65 will receive six physiotherapy sessions over eight weeks. Half will get the combined therapy; the other half will get manual therapy alone. Researchers will measure changes in pain, quality of life, and disability.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
myotensive extraocular muscle techniques and manual therapy
What this could lead to
If it works, this could offer a safe, non-drug way to reduce migraine pain and disability by combining eye muscle therapy with manual therapy.
What could go wrong
This is a small, early-stage trial with no blinding, so results may be influenced by placebo. The extra eye muscle techniques may not add benefit over manual therapy alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 84 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being of legal age. * Having a medical diagnosis of migraine without aura established by a neurologist, according to the criteria of the ICHD-III * Having been diagnosed with migraine for at least one year and experiencing at least one attack per month. * Having been prescribed a specific pharmacological treatment by a specialist physician for at least 6 months. * Participants must attend all assessments with their habitual optical correction fully updated (glasses or contact lenses), ensuring that any refractive error is appropriately corrected. * Presenting symptoms in the oculomotor system, as detailed in the participant information sheet. Exclusion Criteria: * Pregnancy or breastfeeding. * Receiving any other type of physiotherapeutic treatment at the time of the intervention. * Presenting any of the following conditions: chronic respiratory, cardiovascular, and/or musculoskeletal diseases such as polyarthritis, rheumatic muscle inflammation, osteoporosis, or osteoarthritis; other types of headache, other neurological diseases, oncological processes, cognitive, emotional, or psychological disorders; previous surgical interventions or trauma in the cervical region; or diseases specific to the oculomotor system.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Migraine without aura are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

migraine disorder migraine without aura

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Migraine without aura

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universidad from Sevilla

    Seville, Andalusia, 41009, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.